Paradigm Biocapital Advisors »

Tyra Biosciences shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $79M 2.1M 38.30

More positions owned by Paradigm Biocapital Advisors

Arcellx Common Stock (ACLX)
Revolution Medicines (RVMD)
Nuvalent Inc-a (NUVL)
Vaxcyte (PCVX)
Edgewise Therapeutics (EWTX)
Genmab A/s Sponsored Ads (GMAB)
Insmed Com Par $.01 (INSM)
Tarsus Pharmaceuticals (TARS)
Belite Bio Sponsored Ads (BLTE)
Erasca (ERAS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Olema Pharmaceuticals (OLMA)
Terns Pharmaceuticals (TERN)
Oruka Therapeutics (ORKA)
Apogee Therapeutics (APGE)

View all positions for Paradigm Biocapital Advisors

Top funds holding Tyra Biosciences

RA Capital Management
Nextech Invest
Henderson Group
Alta Partners Management Company
TCG Crossover Management
Commodore Capital
BlackRock
Farallon Capital Management
Paradigm Biocapital Advisors
BVF
Vanguard Group
Vanguard Capital Management
5AM Venture Management
Caligan Partners
Logos Global Management

View all funds holding Tyra Biosciences